NeoNotes
Journal Club
Andrew B. Kairalla MD, Editor
Junaid M Khan MD, Guest Editor
8-023 | Additional Comments | Previous
Article | Next Article | Search
| List of Articles | Submit
Comments | Index | FSN Home Page | Subscribe
Now
Serum Amyloid to Diagnose Sepsis
Arnon S,
Litmanovitz I, Regev RH, et al. Serum amyloid A: an early and accurate
marker of neonatal early-onset sepsis. J Perinatol 27: 297-302.
Full Text |
PDF
Objectives: To evaluate the accuracy of serum amyloid A (SAA), an
acute phase protein in the detection of neonatal early-onset sepsis, by means of
a fast automated SAA kit.
Study Design: Full-term infants <72 h of age, who had risk
factors and/or were suspected of having sepsis, were eligible for study. The
levels of SAA were taken at 0, 24 and 48 h post sepsis evaluation. Thirty
matched infants served as a control group for comparing SAA concentrations.
Results: Of 104 infants eligible for entry to the study, 23 had
sepsis and 81 had not sepsis. The SAA levels of the septic group were
significantly higher than those of the nonseptic group at 0, 24 and 48 h (P<0.01
for all time points). In comparison with C-reactive protein (CRP), SAA levels
rose earlier and in a sharper manner, had higher levels and returned faster to
normal values in infants with early onset sepsis. At 0 h post-sepsis evaluation,
serum SAA had an overall better diagnostic accuracy for predicting early onset
sepsis than CRP (sensitivity (96 vs 30%), specificity (95 vs 98%), positive
predictive value (85 vs 78%), negative predictive value (99 vs 83%), positive
likelihood ratio (19 vs 12), and negative likelihood ratio (0.05 vs 0.71).
Conclusion: SAA is advocated as an inflammatory marker of neonatal
early-onset sepsis.
Comments.
This is
an interesting article, however, I have some comments:
1. They grouped both culture proven sepsis & sepsis like illness (clinical
sepsis) into one group, and more than 50% (12 /23) of their "sepsis group" were
actually culture negative. It would have been interesting if they provided more
data comparing serum Amyloid A & CRP levels in sepsis proven, clinical sepsis,
non –septic and control groups.
2. What are the reference values for serum amyloid A levels in newborns? Is the
cut off value they gave in their study the usual cut off value for the test? Is
the test widely available?, Is it reliable, & cost effective?
3. No data was provided for statistical analyses.
In short, we need a lot more studies to prove the value of SAA in diagnosis of
sepsis. JMK.
You may add your own comments to the discussion of this topic by selecting : Submit Comments.